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Abstract
Introduction: There have been few reports of spontaneous regression of malignant pleural
mesothelioma, but the mechanism for this is unknown. We present a case report on a patient with
malignant pleural mesothelioma showing apparent tumor disappearance in a local relapse after
surgery.
Case presentation: A 73-year-old man presented with malignant pleural mesothelioma in the right
thoracic cavity. A pleurectomy was performed, and as expected, the tumor locally relapsed with
increasing chest pain. However, the symptoms suddenly improved while the tumor was apparently
reduced, and spontaneous tumor regression was initially considered. The patient confessed that he
had self-administered a mushroom extract with alternative parasympathetic nerve stimulation
therapy thereafter. The complete disappearance of the tumor was clinically achieved during a
29-month follow-up with continuing self-treatment.
Conclusion: This is the first report describing a malignant pleural mesothelioma patient in Japan
showing long-term complete disappearance of a local relapse after surgery. This event was a tumor
regression possibly due to an immunological effect of combined complementary and alternative
therapy.
Introduction
Although the standard therapy for malignant pleural
mesothelioma (MPM) is still undetermined, the major
therapeutic modality for this disease is surgery, radiation
and chemotherapy. The majority of cases are at an
advanced stage, thus several novel modalities to improve
the overall survival time have been preliminarily explored.
Immunotherapy, molecular-targeted therapy, and gene
therapy are candidate therapies, but cases of long-term
survival are exceptional.
Page 1 of 4
(page number not for citation purposes)In spite of the advanced-stage disease, complete or marked
regression of MPM has been described [1–4]. These
surprising events are mostly due to chemotherapy achieving
complete remission [1], and only three reports have
described spontaneous regression of this disease [2–4].
Recently,apatientwithMPMexperiencedacompletetumor
regression of a local relapse after cytoreduction surgery. It is
possiblethatthisuniquefavorableeventwasduetotheeffect
of combined complementary and alternative self-therapy.
Case presentation
A 73-year-old man with a 75-pack-year history of cigarette
smoking and asbestos exposure between the ages of 30
and 40 years had been admitted to undergo an extra-
pleural pneumonectomy due to MPM in the right pleural
cavity. However, only a cytoreduction pleurectomy was
performed on 30 September 2003 (Figure 1A), because of
the aggressiveness of the local tumor. The lesion remained
mainly in the mediastino-hilar region adjacent to the
carina, esophagus, and the right main bronchus. Histolo-
gically, the tumor was epithelioid type (Figure 1B) with
T4N0, stage IV (IMIG staging). Then, postoperative
intrathoracic chemothermotherapy using carboplatin
(CBDCA, 450mg intrapleurally, one course) was adminis-
tered, followed by systemic chemotherapy using gemcita-
bine (GEM, 0.8mg/m
2, biweekly, 6 courses). Chest
computed tomography (CT) in December 2003 showed
that the effect of these postoperative therapies on the
residual tumor was stable disease (SD).
In May 2004, the patient felt increasing chest pain with
poor general condition. Chest CT showed local relapse
broadly in the right pleural cavity causing airway narrow-
ing (Figure 2A). However, he refused further chemo-
radiation therapy, and in June 2004, without consulting
with the physicians, he orally self-administered a mush-
room extract containing Agaricus blazei Murill Kyowa
(ABMK) [5], in addition to alternative parasympathetic
nerve stimulation therapy in another hospital. This is a
modified acupuncture modality providing possible
immune-modulation [6]. After experiencing high fever
for about 2 weeks, his general condition distinctly
improved. Four months after these therapies, the relapsed
bulky tumor in the pleural cavity had significantly
decreased, and finally completely disappeared on chest
CT (Figure 2B). Then, the patient continued this self-
treatment with neither symptoms nor radiological evi-
denceof tumorrelapse inMay2007.Tumor disappearance
was completely achieved during a 29-month follow-up.
Unfortunately, local relapse was detected on chest CT in
August 2007. In November 2008, although the relapsed
tumor was again growing slowly, the patient was alive
while continuing this self-treatment.
Discussion
The median survival times for patients with an unresectable
or postsurgical recurrent MPM are usually reported to be in
the 6- to 12-month range with the best supportive care, and
evennow,mostchemotherapeuticregimenshaveshownno
or only a minor benefit to the survival rate. In this patient,
although an extrapleural pneumonectomy was initially
selected as the first step, only a cytoreduction pleurectomy
was performed. Therefore, postoperative treatment includ-
ing intrathoracic chemothermotherapy and systemic che-
motherapy was positively administered yielding SD, but
Figure 1.
Macroscopic (A) and microscopic (B) findings of the
surgically resected malignant pleural mesothelioma.
Multiple nodules of malignant pleural mesothelioma were
macroscopically scattered throughout the resected parietal
pleura (A). Hematoxylin-eosin-stained light micrograph of
the resected pleural tumor. The lesion was histologically
diagnosed as epithelioid-type malignant pleural
mesothelioma (B).
Figure 2.
Local relapse before treatment (A) and tumor
disappearance after treatment (B) on chest computed
tomography. Chest computed tomography scan (A) before
the combined therapy showing local relapse of malignant
pleural mesothelioma in the right pleural cavity, especially with
tumor mass formation in the mediastino-hilar region causing
airway narrowing. White arrows show relapsed lesions in the
right pleural cavity. After the combined therapy, chest
computed tomography scan (B) shows complete tumor
disappearance in the right pleural cavity.
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Surprisingly, considering the usually poor prognosis of this
disease,thepresentclinicalcourseafteralocalrelapseseems
unique. It is extremely interesting to elucidate the mechan-
ism of regression of the tumor.
Initially, the disappearance of the tumor was viewed as a
result of the delayed effect of postoperative chemotherapy;
however, by reviewing the clinical course and condition of
the patient, this judgment was found to be negative. In
addition, since the patient had taken non-steroidal anti-
inflammatory drugs (NSAIDs) continuously after under-
going a pleurectomy, it also seemed that this medication
had had little effect on the observed tumor regression.
Next, a so-called “spontaneous regression” of the tumor
was considered, because the patient did not reveal that he
had received the “complementary or alternative combined
therapy”. Spontaneous regression of MPM has been
described in only three reports [2–4]. A clinical summary
of these reported cases is shown in Table 1. According to
these reports, spontaneous regression of MPM may be
strongly associated with lymphocyte-mediated immunity.
Robinson et al. [2] emphasized an association between
MPM regression and some immunological mechanism
based on the histological observation of massive lym-
phoid infiltration within the tumor tissue. Pilling et al. [3]
also reported similar histological findings. In our patient,
however, such histological evidence was not seen in the
surgically resected tissue.
Thirdly, after having revealed this “hidden combined
therapy”, tumor disappearance could be rather considered
as a “therapeutic effect” of achieving complete remission.
ABMK, a mushroom extract, is considered a health food in
many countries after it was reported to be a potential
source of anti-tumor, anti-metastatic, cytotoxic and
immunoactive compounds [5, 7]. Experimentally, Kimura
et al. [7] showed thatsome substances isolated from ABMK
inhibited tumor growth through the mechanism of both
anti-angiogenic and immune-modulatory activity. Ahn et
al. [5] reported that natural killer cell activity was clinically
elevated by ABMK-treated gynecological cancer patients.
Another therapy, parasympathetic nerve stimulation ther-
apy with a minor modification using a laser machine, is
widely performed as alternative therapy for patients
suffering from cancer as well as various other types of
disease in Japan [6]. In particular, for cancer-bearing
patients, it was said that acupuncture therapy could
provide a beneficial effect in anti-cancer treatment by
enhancing the cellular immune function [8]; however, so
far, there has been no report describing the clinically
complete remission of malignancy by these therapies.
Alternative, but more scientific, immunotherapy has been
clinically explored to treat MPM [9]. One is specific
immunotherapy which targets particular antigens in MPM
tissue, and the other is a non-specific, but anti-tumor
immunotherapy using such cytokines as interleukin 2
(IL-2), tumor necrosis factor (TNF), and interferon (INF)
[9]. In fact, complete remission of MPM was experienced
by INF administration through intra-pleural administra-
tion [10].
In our patient, considering that the timing of the improve-
ments in his general condition after a high fever and tumor
disappearance accorded with the influence of this “com-
plementary or alternative treatment”, it is likely that this
successful clinical outcome resulted in complete remission.
However, it is unknown whether the AGMK or parasympa-
thetic nerve stimulation or both combined brought about
the most favorable effect, and importantly, there are no
scientific grounds to confirm the direct effect of this
treatment. Several immunological blood parameters such
as serum IL-2, INF-alpha, INF-gamma, and CD4/CD8 ratio
were examined after the tumor disappearance, but all were
within the normal range (data not shown).
Table 1. Reported cases of spontaneous regression of malignant pleural mesothelioma
Reporter Country Year Gender Age Histology Previous therapy Patient Time to regression Outcome Mechanism
Period of regression
Robinson et al. [2]
Australia*
2001 Female 54 Mixed No 3 months Died Immunological
reaction?
(with lymphoid infiltration) Unknown
Pilling et al. [3] UK** 2007 Male 58 Epithelioid Surgery Unknown Survival without
relapse
Host response
(with inflammatory response) 7 years
Allen RKA [4]
Australia**
2007 Female 61 Epithelioid No 6 months Survival without
relapse
Immunological
reaction?
(poorly differentiated) 5 years
The present case
Japan**
2009 Male 73 Epithelioid Surgery
Chemotherapy
4 months
29 months
Survival with
re-relapse
Complementary and alternative therapy?
*Case of spontaneous marked regression
**Cases of spontaneous complete regression
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a clinical tumor disappearance after a local relapse during
a 29-month follow-up period. The mechanism of this
tumor disappearance could not be sufficiently explained.
Importantly, the mechanism of spontaneous regression of
this disease in previous reports [2–4] is considered to be
strongly associated with some immunological reaction,
and the good effect of such complementary or alternative
treatment modalities [5–8] is also caused by a similar
immune response. Considering these data together, some
immunological reactions of the host to the tumor are thus
suggested to be responsible in this patient.
Conclusion
This is the first report describing a MPM patient in Japan
showing long-term complete disappearance of a local
relapse after surgery. The mechanism of this surprising
tumor disappearance cannot be categorically explained.
However, the clinical course suggests that some immuno-
logical reactions of the host to the tumor may be
responsible.
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